City

Jinan (2)

Fuzhou (1)

Guangzhou (1)

Huizhou (1)

Jieyang (1)

Meizhou (1)

Wuhan (1)

Condition

Pirfenidone (4)

Connective Tissue Diseases (2)

Interstitial Lung Disease (2)

Head and Neck Squamous Cell Carcinoma (1)

Novel Coronavirus Pneumonia (1)

Pneumonia (1)

Radiosensitizer (1)

Radiotherapy (1)

Overall Status

Recruiting (3)

Unknown status (1)

Sign in for free

Phase

phase 4 (2)

phase 2 (1)

phase 3 (1)

Sponsor

Qilu Hospital of Shandong University (2)

Huilan Zhang (1)

Nanfang Hospital, Southern Medical University (1)

Collaborator

Intervention

pirfenidone (4)

dmards (1)

glucocorticoid and immunosuppressant (1)

placebo (1)

Study Documents

Intervention Type

drug (4)

Funder Type

Other (4)

Study Type

Interventional (4)

Pirfenidone

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Head and Neck Squamous Cell Carcinoma, Radiotherapy, Radiosensitizer Trial in China (Pirfenidone, Placebo)

Recruiting

Head and Neck Squamous Cell Carcinoma
+3 more

Pirfenidone
Placebo

Guangzhou, Guangdong, China
+4 more

Nov 16, 2023

Pirfenidone, Connective Tissue Diseases, Interstitial Lung Disease Trial in Jinan (Pirfenidone, glucocorticoid and

Recruiting

Pirfenidone
+2 more

Pirfenidone
glucocorticoid and immunosuppressant

Jinan, Shandong, China

Qilu Hospital

Aug 16, 2022

Pirfenidone, Connective Tissue Diseases, Interstitial Lung Disease Trial in Jinan (Pirfenidone, DMARDs)

Recruiting

Pirfenidone
+2 more

Jinan, Shandong, China

Qilu Hospital

Jun 9, 2021

Novel Coronavirus Pneumonia, Pneumonia, Pirfenidone Trial in Wuhan (pirfenidone)

Unknown status

Novel Coronavirus Pneumonia
+2 more

pirfenidone

Wuhan, Hubei, China

Tongji hospital affiliated to huazhong university of science and

Feb 21, 2020